Ameluz (topical)

Common Brands Ameluz (topical)
Drug Class
Topical skin product
Controlled Substance Classification
Not a controlled medication
Generic Status
No Lower-cost generic available
Availability
Prescription only
Kristianne Hannemann, PharmD
Kristianne Hannemann, PharmD
Read More
Medically reviewed by Kristianne Hannemann, PharmD last update on 20/12/2023

Overview

Ameluz is a topical gel medication primarily used in photodynamic therapy (PDT) for the treatment of actinic keratosis (AK), a common skin condition caused by prolonged sun exposure. The gel contains 10% aminolevulinic acid hydrochloride (ALA), which is activated by light to destroy abnormal skin cells. It is applied directly to the affected area and then exposed to a specific wavelength of light, typically blue light, to activate the medication. Ameluz is FDA-approved and has demonstrated efficacy in clinical trials for AK lesions on the face and scalp.

DRUG STATUS

Availability

Prescription only

Pregnancy & Lactation

Pregnancy